Skip to content

Ultragenyx Pharmaceutical

US · RARE #3012 by market cap Listed 1970
14.89 +0.43 +2.97%
Live - 5344 symbols - heartbeat 225s ago · 2026-10-08 07:08
Pre-market 14.63 -1.73%
After-hours 14.85 -0.27%
Overnight 14.89 0.00%
Market cap
1.47B
P/B
-5.04
EPS
-5.83
Reader sentiment Are you bullish or bearish on RARE?

Anonymous reader poll. Unscientific, not investment advice.

Ultragenyx Pharmaceutical shares were changing hands at 14.89, up 2.97% on the day. Its market capitalisation is about 1.47B, the #3012 most valuable US-listed company we track. Wall Street's 19-analyst consensus lands on Buy, with a price target averaging 32.06 (+115% from here). The shares sit 8% of the way up their 52-week range of 12.73 to 39.89.

✦ StockVane Quant Insights how this is computed

Quant Rating E Strong Sell
  • Below its 200-day average and near the bottom of the universe on momentum.
  • Signal has read STRONG SELL for 4 weeks.
See the full rating history & follow-along return →
Quant Sentiment Bearish
  • Recent price momentum is -54.2% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 16.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is above its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

35.8712.8814.892026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -0.93%
1M -2.68%
3M -58.49%
6M -35.68%
YTD -35.26%
1Y -49.93%
3Y -57.73%
5Y -82.57%

Key statistics

Price & volume

Prev close
14.46
Open
14.37
Day range
14.35 - 15.25
Avg price
14.89
Volume
4.16M
Turnover
61.99M
Amplitude
6.28%
52-week range
12.73 - 39.89

Valuation

P/E
-2.55
P/E (TTM)
-2.55
P/B
-5.04
EPS
-5.83
Net profit
-574.77M
Net assets
-291.03M

Share structure

Market cap
1.47B
Float cap
1.20B
Shares out
98.59M
Float shares
80.72M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 8% of range
12.73 39.89

62.7% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-32.90M net over the window

Short interest

Shares short
16.57M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Ultragenyx Pharmaceutical (RARE)?

Ultragenyx Pharmaceutical last traded at 14.89. The quote on this page refreshes every few seconds while US markets are open.

What is Ultragenyx Pharmaceutical's market cap?

About 1.47B.

What is the P/E ratio of Ultragenyx Pharmaceutical?

The trailing twelve-month P/E is -2.55. The Valuation tab shows it against the stock's own five-year range.

Does Ultragenyx Pharmaceutical pay a dividend?

Ultragenyx Pharmaceutical does not currently pay a regular dividend.

Is Ultragenyx Pharmaceutical a buy according to analysts?

The consensus of 19 analysts is a Buy rating, with an average 12-month price target of 32.06, which implies 115.3% upside from the current price. This is not investment advice.

What is Ultragenyx Pharmaceutical's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Ultragenyx Pharmaceutical a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-10-08 07:08:01 · For reference only, not investment advice and not tailored to your situation.